Advertisement

Meta-Analysis of Trials on Mortality After Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Stable Coronary Heart Disease and Objective Evidence of Myocardial Ischemia

Published:February 11, 2015DOI:https://doi.org/10.1016/j.amjcard.2015.01.556
      Outcomes of percutaneous coronary intervention (PCI) versus medical therapy (MT) in the management of stable ischemic heart disease (SIHD) remain controversial, with some but not all studies showing improved results in patients with ischemia. We sought to elucidate whether PCI improves mortality compared to MT in patients with objective evidence of ischemia (assessed using noninvasive imaging or its invasive equivalent). We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing PCI to MT in patients with SIHD. To maintain a high degree of specificity for ischemia, studies were only included if ischemia was defined on the basis of noninvasive stress imaging or abnormal fractional flow reserve. The primary outcome was all-cause mortality. We identified 3 RCTs (Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction II, Fractional Flow Reserve versus Angiography for Multivessel Evaluation 2, and a substudy of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation trial) enrolling a total of 1,557 patients followed for an average of 3.0 years. When compared with MT in this population of patients with objective ischemia, PCI was associated with lower mortality (hazard ratio 0.52, 95% confidence interval 0.30 to 0.92, p = 0.02). There was no evidence of study heterogeneity or bias among included trials. In this meta-analysis of published RCTs, PCI was shown to have a mortality benefit over MT in patients with SIHD and objective assessment of ischemia using noninvasive imaging or its invasive equivalent. In conclusion, this study provides insight into the management of a higher-risk SIHD population that is the focus of the ongoing International Study of Comparative Health Effectiveness with Medical and Invasive Approaches trial.
      To read this article in full you will need to make a payment

      References

        • Boden W.E.
        • O'Rourke R.A.
        • Teo K.K.
        • Hartigan P.M.
        • Maron D.J.
        • Kostuk W.J.
        • Knudtson M.
        • Dada M.
        • Casperson P.
        • Harris C.L.
        • Chaitman B.R.
        • Shaw L.
        • Gosselin G.
        • Nawaz S.
        • Title L.M.
        • Gau G.
        • Blaustein A.S.
        • Booth D.C.
        • Bates E.R.
        • Spertus J.A.
        • Berman D.S.
        • Mancini G.B.
        • Weintraub W.S.
        • Courage Trial Research Group
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        • Group B.D.S.
        • Frye R.L.
        • August P.
        • Brooks M.M.
        • Hardison R.M.
        • Kelsey S.F.
        • MacGregor J.M.
        • Orchard T.J.
        • Chaitman B.R.
        • Genuth S.M.
        • Goldberg S.H.
        • Hlatky M.A.
        • Jones T.L.
        • Molitch M.E.
        • Nesto R.W.
        • Sako E.Y.
        • Sobel B.E.
        A randomized trial of therapies for type 2 diabetes and coronary artery disease.
        N Engl J Med. 2009; 360: 2503-2515
        • Dorbala S.
        • Di Carli M.F.
        • Beanlands R.S.
        • Merhige M.E.
        • Williams B.A.
        • Veledar E.
        • Chow B.J.
        • Min J.K.
        • Pencina M.J.
        • Berman D.S.
        • Shaw L.J.
        Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.
        J Am Coll Cardiol. 2013; 61: 176-184
        • Iskander S.
        • Iskandrian A.E.
        Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging.
        J Am Coll Cardiol. 1998; 32: 57-62
        • Pavin D.
        • Delonca J.
        • Siegenthaler M.
        • Doat M.
        • Rutishauser W.
        • Righetti A.
        Long-term (10 years) prognostic value of a normal thallium-201 myocardial exercise scintigraphy in patients with coronary artery disease documented by angiography.
        Eur Heart J. 1997; 18: 69-77
        • Schwitter J.
        • Arai A.E.
        Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance.
        Eur Heart J. 2011; 32: 799-809
        • Vanzetto G.
        • Ormezzano O.
        • Fagret D.
        • Comet M.
        • Denis B.
        • Machecourt J.
        Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up.
        Circulation. 1999; 100: 1521-1527
        • Fihn S.D.
        • Gardin J.M.
        • Abrams J.
        • Berra K.
        • Blankenship J.C.
        • Dallas A.P.
        • Douglas P.S.
        • Foody J.M.
        • Gerber T.C.
        • Hinderliter A.L.
        • King 3rd, S.B.
        • Kligfield P.D.
        • Krumholz H.M.
        • Kwong R.Y.
        • Lim M.J.
        • Linderbaum J.A.
        • Mack M.J.
        • Munger M.A.
        • Prager R.L.
        • Sabik J.F.
        • Shaw L.J.
        • Sikkema J.D.
        • Smith Jr., C.R.
        • Smith Jr., S.C.
        • Spertus J.A.
        • Williams S.V.
        • American College of Cardiology Foundation
        • American Heart Association Task Force on Practice Guidelines
        • American College of Physicians
        • American Association for Thoracic Surgery
        • Preventive Cardiovascular Nurses Association
        • Society for Cardiovascular Angiography and Interventions
        • Society of Thoracic Surgeons
        2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American college of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2012; 60: e44-e164
        • Bangalore S.
        • Pursnani S.
        • Kumar S.
        • Bagos P.G.
        Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease.
        Circulation. 2013; 127: 769-781
        • Liberati A.
        • Altman D.G.
        • Tetzlaff J.
        • Mulrow C.
        • Gotzsche P.C.
        • Ioannidis J.P.
        • Clarke M.
        • Devereaux P.J.
        • Kleijnen J.
        • Moher D.
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
        Ann Intern Med. 2009; 151: W65-94
        • Shaw L.J.
        • Weintraub W.S.
        • Maron D.J.
        • Hartigan P.M.
        • Hachamovitch R.
        • Min J.K.
        • Dada M.
        • Mancini G.B.
        • Hayes S.W.
        • O'Rourke R.A.
        • Spertus J.A.
        • Kostuk W.
        • Gosselin G.
        • Chaitman B.R.
        • Knudtson M.
        • Friedman J.
        • Slomka P.
        • Germano G.
        • Bates E.R.
        • Teo K.K.
        • Boden W.E.
        • Berman D.S.
        Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.
        Am Heart J. 2012; 164: 243-250
        • De Bruyne B.
        • Pijls N.H.
        • Kalesan B.
        • Barbato E.
        • Tonino P.A.
        • Piroth Z.
        • Jagic N.
        • Möbius-Winkler S.
        • Rioufol G.
        • Witt N.
        • Kala P.
        • MacCarthy P.
        • Engström T.
        • Oldroyd K.G.
        • Mavromatis K.
        • Manoharan G.
        • Verlee P.
        • Frobert O.
        • Curzen N.
        • Johnson J.B.
        • Jüni P.
        • Fearon W.F.
        • FAME 2 Trial Investigators
        Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.
        N Engl J Med. 2012; 367: 991-1001
        • Erne P.
        • Schoenenberger A.W.
        • Burckhardt D.
        • Zuber M.
        • Kiowski W.
        • Buser P.T.
        • Dubach P.
        • Resink T.J.
        • Pfisterer M.
        Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.
        JAMA. 2007; 297: 1985-1991
        • Kereiakes D.J.
        • Teirstein P.S.
        • Sarembock I.J.
        • Holmes Jr., D.R.
        • Krucoff M.W.
        • O'Neill W.W.
        • Waksman R.
        • Williams D.O.
        • Popma J.J.
        • Buchbinder M.
        • Mehran R.
        • Meredith I.T.
        • Moses J.W.
        • Stone G.W.
        The truth and consequences of the COURAGE trial.
        J Am Coll Cardiol. 2007; 50: 1598-1603
        • Hachamovitch R.
        • Hayes S.W.
        • Friedman J.D.
        • Cohen I.
        • Berman D.S.
        Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.
        Circulation. 2003; 107: 2900-2907
        • Hachamovitch R.
        • Rozanski A.
        • Shaw L.J.
        • Stone G.W.
        • Thomson L.E.
        • Friedman J.D.
        • Hayes S.W.
        • Cohen I.
        • Germano G.
        • Berman D.S.
        Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.
        Eur Heart J. 2011; 32: 1012-1024
        • Damman P.
        • Wallentin L.
        • Fox K.A.
        • Windhausen F.
        • Hirsch A.
        • Clayton T.
        • Pocock S.J.
        • Lagerqvist B.
        • Tijssen J.G.
        • de Winter R.J.
        Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR).
        Circulation. 2012; 125: 568-576
        • Prasad A.
        • Gersh B.J.
        • Bertrand M.E.
        • Lincoff A.M.
        • Moses J.W.
        • Ohman E.M.
        • White H.D.
        • Pocock S.J.
        • McLaurin B.T.
        • Cox D.A.
        • Lansky A.J.
        • Mehran R.
        • Stone G.W.
        Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
        J Am Coll Cardiol. 2009; 54: 477-486
        • Moussa I.D.
        • Klein L.W.
        • Shah B.
        • Mehran R.
        • Mack M.J.
        • Brilakis E.S.
        • Reilly J.P.
        • Zoghbi G.
        • Holper E.
        • Stone G.W.
        Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).
        J Am Coll Cardiol. 2013; 62: 1563-1570
        • Wijeysundera H.C.
        • Bennell M.C.
        • Qiu F.
        • Ko D.T.
        • Tu J.V.
        • Wijeysundera D.N.
        • Austin P.C.
        Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study.
        J Gen Intern Med. 2014; 29: 1031-1039
        • Stergiopoulos K.
        • Boden W.E.
        • Hartigan P.
        • Mobius-Winkler S.
        • Hambrecht R.
        • Hueb W.
        • Hardison R.M.
        • Abbott J.D.
        • Brown D.L.
        Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials.
        JAMA Intern Med. 2014; 174: 232-240
        • Gianrossi R.
        • Detrano R.
        • Mulvihill D.
        • Lehmann K.
        • Dubach P.
        • Colombo A.
        • McArthur D.
        • Froelicher V.
        Exercise-induced ST depression in the diagnosis of coronary artery disease. a meta-analysis.
        Circulation. 1989; 80: 87-98
        • Mancini G.B.
        • Hartigan P.M.
        • Shaw L.J.
        • Berman D.S.
        • Hayes S.W.
        • Bates E.R.
        • Maron D.J.
        • Teo K.
        • Sedlis S.P.
        • Chaitman B.R.
        • Weintraub W.S.
        • Spertus J.A.
        • Kostuk W.J.
        • Dada M.
        • Booth D.C.
        • Boden W.E.
        Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
        JACC Cardiovasc Interv. 2014; 7: 195-201
        • Pursnani S.
        • Korley F.
        • Gopaul R.
        • Kanade P.
        • Chandra N.
        • Shaw R.E.
        • Bangalore S.
        Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.
        Circ Cardiovasc Interv. 2012; 5: 476-490
        • Schomig A.
        • Mehilli J.
        • de Waha A.
        • Seyfarth M.
        • Pache J.
        • Kastrati A.
        A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease.
        J Am Coll Cardiol. 2008; 52: 894-904
        • Baber U.
        • Mehran R.
        • Sharma S.K.
        • Brar S.
        • Yu J.
        • Suh J.W.
        • Kim H.S.
        • Park S.J.
        • Kastrati A.
        • de Waha A.
        • Krishnan P.
        • Moreno P.
        • Sweeny J.
        • Kim M.C.
        • Suleman J.
        • Pyo R.
        • Wiley J.
        • Kovacic J.
        • Kini A.S.
        • Dangas G.D.
        Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials.
        J Am Coll Cardiol. 2011; 58: 1569-1577
        • Freixa X.
        • Dzavik V.
        • Forman S.A.
        • Rankin J.M.
        • Buller C.E.
        • Cantor W.J.
        • Ruzyllo W.
        • Reynolds H.R.
        • Lamas G.A.
        • Hochman J.S.
        Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT).
        Am Heart J. 2012; 163: 1011-1018
        • Ahn J.M.
        • Kang S.J.
        • Yoon S.H.
        • Park H.W.
        • Kang S.M.
        • Lee J.Y.
        • Lee S.W.
        • Kim Y.H.
        • Lee C.W.
        • Park S.W.
        • Mintz G.S.
        • Park S.J.
        Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies.
        Am J Cardiol. 2014; 113: 1338-1347
        • Pijls N.H.
        • Fearon W.F.
        • Tonino P.A.
        • Siebert U.
        • Ikeno F.
        • Bornschein B.
        • van't Veer M.
        • Klauss V.
        • Manoharan G.
        • Engstrom T.
        • Oldroyd K.G.
        • Ver Lee P.N.
        • MacCarthy P.A.
        • De Bruyne B.
        • FAME Study Investigators
        Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.
        J Am Coll Cardiol. 2010; 56: 177-184